1.A Case of Skin and Soft Tissue Infection Caused by Mycobacterium abscessus.
Yeon Sook KIM ; Il Chul HONG ; Choon Kwan KIM ; Shin Woo KIM ; Sungmin KIM ; Kyong Ran PECK ; Bum Joon KIM ; Yoon Hoh KOOK ; Jae Hoon SONG
Korean Journal of Infectious Diseases 2000;32(1):64-68
Mycobacterium abscessus (formerly M. chelonae sub-species abscessus) is an acid-fast bacillus classified as pathogenic "rapid growing" nontuberculous mycobacteria. Even though these organisms are ubiquitous in the environment, it is an uncommon cause of human diseases. M. abscessus can cause skin and soft tissue infection associated with a penetrating wound or a foreign body but it can spread to viscera other than the lungs leading to a variety of infections. The single most important factor determining the course and prognosis of M. abscessus infection is the underlying immune status of the hosts. There have been no reports of skin and soft tissue infection caused by M. abscessus in Korea. We experienced a case of skin and soft tissue infection with M. abscessus. A 43-year-old female patient developed necrotizing infection in the skin, soft tissue and fascia in the lower extremity without a definite preceding cause. She was treated successfully with prolonged drug therapy including clarithromycin, and surgical debridement.
Adult
;
Bacillus
;
Clarithromycin
;
Debridement
;
Drug Therapy
;
Fascia
;
Female
;
Foreign Bodies
;
Humans
;
Korea
;
Lower Extremity
;
Lung
;
Mycobacterium*
;
Nontuberculous Mycobacteria
;
Prognosis
;
Skin*
;
Soft Tissue Infections*
;
Viscera
;
Wounds, Penetrating
2.Polysaccharides isolated from Phellinus gilvus enhances dermal wound healing in streptozotocin-induced diabetic rats.
Jae Sung BAE ; Kwang Ho JANG ; Hee Kyung JIN
Journal of Veterinary Science 2005;6(2):161-164
Dermal wound healing is a complex process that involved inflammation leading to re-epithelialization, granulation tissue, and tissue remodeling. Previous studies from our laboratory have shown that polysaccharides isolated from fungus, Phellinus gilvus (PG) have various anti-inflammatory activities. In present study, we have assessed the effect of polysaccharides from PG on the dermal wound healing of polysaccharides from PG in streptozotocin-induced diabetic rat model. Six of 6-mm circular wounds were created with biopsy punch on the 4th day after induction of diabetes. After 24 hours, each test substance was applied to the wound twice a day for next 5 days. Circular wounds treated with PG showed significantly reduced wound contraction and complete reepithelialization, as compared to wounds of non-treated (p < 0.05). These results show that polysaccharides isolated from PG enhanced wound repair in diabetic impaired healing, and could be developed as a wound healing agent in such clinical settings.
Administration, Cutaneous
;
Animals
;
Anti-Inflammatory Agents/pharmacology
;
Basidiomycota/*metabolism
;
Diabetes Mellitus, Experimental/*pathology
;
Histocytochemistry
;
Male
;
Polysaccharides/isolation&purification/*pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Skin/*injuries
;
Streptozocin
;
Wound Healing/*drug effects
;
Wounds, Penetrating/*drug therapy
3.A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study.
Han-jing GAO ; Qing SONG ; Fa-qin LV ; Shan WANG ; Yi-ru WANG ; Yu-kun LUO ; Xing-guo MEI ; Jie TANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(5):707-711
Gabexate mesilate (GM) is a trypsin inhibitor, and mainly used for treatment of various acute pancreatitis, including traumatic pancreatitis (TP), edematous pancreatitis, and acute necrotizing pancreatitis. However, due to the characteristics of pharmacokinetics, the clinical application of GM still needs frequently intravenous administration to keep the blood drug concentration, which is difficult to manage. Specially, when the blood supply of pancreas is directly damaged, intravenous administration is difficult to exert the optimum therapy effect. To address it, a novel thermosensitive in-situ gel of gabexate mesilate (GMTI) was developed, and the optimum formulation of GMTI containing 20.6% (w/w) P-407 and 5.79% (w/w) P188 with different concentrations of GM was used as a gelling solvent. The effective drug concentration on trypsin inhibition was examined after treatment with different concentrations of GMTI in vitro, and GM served as a positive control. The security of GMTI was evaluated by hematoxylin-eosin (HE) staining, and its curative effect on grade II pancreas injury was also evaluated by testing amylase (AMS), C-reactive protein (CRP) and trypsinogen activation peptide (TAP), and pathological analysis of the pancreas. The trypsin activity was slightly inhibited at 1.0 and 5.0 mg/mL in GM group and GMTI group, respectively (P<0.05 vs. P-407), and completely inhibited at 10.0 and 20.0 mg/mL (P<0.01 vs. P-407). After local injection of 10 mg/mL GMTI to rat leg muscular tissue, muscle fiber texture was normal, and there were no obvious red blood cells and infiltration of inflammatory cells. Furthermore, the expression of AMS, CRP and TAP was significantly increased in TP group as compared with control group (P<0.01), and significantly decreased in GM group as compared with TP group (P<0.01), and also slightly inhibited after 1.0 and 5.0 mg/mL GMTI treatment as compared with TP group (P<0.05), and significantly inhibited after 10.0 and 20.0 mg/mL GMTI treatment as compared with TP group (P<0.01). HE staining results demonstrated that pancreas cells were uniformly distributed in control group, and they were loosely arranged, partially dissolved, with deeply stained nuclei in TP group. Expectedly, after gradient GMTI treatment, pancreas cells were gradually restored to tight distribution, with slightly stained nuclei. This preliminary study indicated that GMTI could effectively inhibit pancreatic enzymes, and alleviate the severity of trauma-induced pancreatitis, and had a potential drug developing and clinic application value.
Amylases
;
metabolism
;
Animals
;
C-Reactive Protein
;
metabolism
;
Delayed-Action Preparations
;
chemical synthesis
;
pharmacokinetics
;
pharmacology
;
Gabexate
;
chemistry
;
pharmacokinetics
;
pharmacology
;
Gels
;
Male
;
Muscle, Skeletal
;
drug effects
;
enzymology
;
Oligopeptides
;
metabolism
;
Pancreas
;
drug effects
;
enzymology
;
pathology
;
Pancreatitis
;
drug therapy
;
enzymology
;
etiology
;
pathology
;
Poloxamer
;
chemistry
;
Rats
;
Rats, Sprague-Dawley
;
Serine Proteinase Inhibitors
;
chemistry
;
pharmacokinetics
;
pharmacology
;
Temperature
;
Wounds, Penetrating
;
complications
;
drug therapy
;
enzymology
;
pathology